Stay updated on Chemo vs. Chemo+Pembrolizumab in Esophageal Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Chemo vs. Chemo+Pembrolizumab in Esophageal Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo vs. Chemo+Pembrolizumab in Esophageal Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page. Notices regarding government funding and the previous revision (v3.4.1) were removed; no trial details or functionality were altered.
    Difference
    0.4%
    Check dated 2026-02-11T10:59:25.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    A government funding notice banner has been added and the revision updated to v3.4.1. The previous v3.4.0 reference was removed.
    Difference
    0.4%
    Check dated 2026-02-04T06:22:33.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page adds a glossary toggle and updates QC-related labels ('Last Update Submitted that Met QC Criteria') as well as the policy note 'No FEAR Act Data' and a new 'Revision: v3.4.0' tag, replacing the previous wording. These changes are cosmetic and administrative and do not modify the study data or results.
    Difference
    0.2%
    Check dated 2026-01-28T04:30:41.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a new revision label: Revision: v3.3.4, replacing Revision: v3.3.3. This is a minor site maintenance update and does not affect the study details, eligibility criteria, locations, or available actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:18:20.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    A unified Locations section now lists multiple Chinese regions (Anhui, Beijing Municipality, Fujian, Guangdong, Heilongjiang, Hunan, Jiangsu, Jilin, Shannxi, Zhejiang) and removes per-region location headers.
    Difference
    1%
    Check dated 2025-12-23T09:42:49.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.2, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:13:50.000Z thumbnail image

Stay in the know with updates to Chemo vs. Chemo+Pembrolizumab in Esophageal Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo vs. Chemo+Pembrolizumab in Esophageal Carcinoma Clinical Trial page.